IL6 and hematoma: Increased serum levels of IL-6 and IL-10 were detected in intraparenchymal hemorrhage (76), and higher admission IL-6 levels were associated with unfavorable 90-day functional outcomes and hematoma and perihematomal edema volumes (77).